.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers recently presented findings from the TOCEM trial, which evaluated contrast reactions in CEM over three years of annual screening. The prospective study monitored 1,651 women with a personal history of breast cancer who received a total of 3,873 injections of iopamidol. As contrast-enhanced mammography (CEM) becomes a more frequent supplemental screening tool, understanding its safety profile is essential for radiologists and oncologists alike.
The results showed that only 38 out of 3,873 injections resulted in a reaction, equating to a low overall rate of 0.98%. Specifically, allergic-like reactions were the most common, appearing in 0.65% of cases. Most of these (80%) were cutaneous, such as hives or rashes. Additionally, the study noted that patients receiving contrast for the first time had a significantly higher risk (1.96%) compared to those with prior uneventful exposure (0.42%).
Furthermore, the study identified five delayed allergic-like reactions. These symptoms appeared between one and seven days after the initial administration. Only two reactions were severe enough to prevent the completion of imaging. However, most reactions were mild, although 60% of those with allergic-like symptoms required medication for management. Consequently, CEM remains a safe supplemental screening tool for high-risk populations. Clinicians should still remain vigilant for delayed cutaneous symptoms even after the patient leaves the clinic.
Based on the TOCEM trial data, the overall incidence of contrast reactions is low, at approximately 0.98% across thousands of injections.
Yes. The study found that contrast-naïve patients had a significantly higher reaction rate (1.96%) compared to those with prior uneventful exposure (0.42%).
Delayed reactions are primarily cutaneous, such as hives or rashes, and can occur between one and seven days after the procedure.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Healthcare providers should perform their own independent assessment. Refer to the latest local and national guidelines for clinical practice.
References
Gu L et al. Prevalence of Acute and Delayed Contrast Reactions With Multiple Exposures to Contrast-Enhanced Mammography-Experience From the TOCEM Trial. J Breast Imaging. 2026 Feb 09. doi: undefined. PMID: 41661649.
Zanardo M, et al. Adverse events in contrast-enhanced mammography: a systematic review and meta-analysis. European Radiology. 2023;33(10):6741-6751.
American College of Radiology. ACR Manual on Contrast Media. 2023. URL: https://www.acr.org/Clinical-Resources/Contrast-Manual
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study of 3,873 injections reveals that contrast reactions in CEM are rare (0.98%), with most being mild allergic-like cutaneous events....
6 months ago
A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today
A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday
A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today
Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today
The Supreme Court of India has sharply criticized the Food Safety and Standards Authority of India for delaying front-of-package warning labels. With non-communicable diseases causing over 6 million deaths annually, clear nutritional warnings are critical to combat childhood obesity, diabetes, and cardiovascular risk.
Today
